)
Edge14 Nov 2025
Ball: The King of Cans
From a 19th-century glass-jar legacy to a global plant network, Ball is now a pure-play aluminum can partner to the world's biggest beverage brands.
Gland Pharma (GLAND) investor relations material
Gland Pharma Q2 25/26 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 25/26 earnings summary3 Nov, 2025
Executive summary
Q2 FY26 consolidated revenue grew 6% year-over-year to ₹14,869 million, with PAT up 12% to ₹1,837 million; H1 FY26 revenue rose 7% and PAT 30% year-over-year.
Strong performance in the US (up 10% YoY) and Europe (up 16% YoY), with Cenexi revenue up 21% YoY in Q2 FY26.
Management expects robust H2 FY26 growth, driven by new launches, operational improvements at Cenexi, and capacity expansion.
Strategic focus remains on growth, capability, efficiency, and return on capital, aiming to build a high-end, innovation-driven CDMO and specialty injectables business.
U.S. market performance was robust, aided by the absence of new tariffs on generics and successful launches in complex injectables and CDMO segments.
Financial highlights
Q2 FY26 consolidated revenue was ₹14,869 million, up 6% YoY; H1 FY26 revenue reached ₹29,925 million, up 7% YoY.
Q2 FY26 gross profit increased 12% YoY to ₹9,331 million (margin 63%); H1 gross profit was ₹19,175 million (margin 64%), up 15% YoY.
Q2 FY26 EBITDA was ₹3,139 million (21% margin); adjusted EBITDA up 13% YoY to ₹3,355 million (23% margin); H1 adjusted EBITDA was ₹7,092 million (24% margin), up 26% YoY.
Q2 FY26 PAT was ₹1,837 million (12% margin); H1 PAT was ₹3,992 million (13% margin), up 30% YoY.
Cenexi revenue grew 21% YoY in Q2 FY26 and 20% in H1; EBITDA losses reduced to ₹530 million from ₹971 million.
Outlook and guidance
Management maintains mid-teens consolidated revenue growth guidance for FY26, with stronger H2 expected due to major product launches and Cenexi turnaround.
Cenexi is targeted to achieve break-even or slight profitability by Q3/Q4 FY26, with €50 million quarterly revenue as the key threshold.
Complex injectables, GLP-1s, and CDMO expansion are expected to drive sustainable long-term growth, with significant capacity expansion underway.
Commercialization of co-developed products anticipated to begin in FY28.
What is Cenexi's H2 FY26 financial contribution outlook?
GLP-1 capacity expansion timeline and revenue impact?
Co-development pipeline commercialization timeline?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Gland Pharma earnings date
Q3 202628 Jan, 2026
Next Gland Pharma earnings date
Q3 202628 Jan, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Gland Pharma Limited manufactures and markets injectable pharmaceutical products. Its product portfolio includes vials, pre-filled syringes, and infusion bags, primarily for hospital and clinical use. The company is headquartered in Hyderabad, India, and its shares are listed on the NSE.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage